Roby Thomas is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 52 publications with 419 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5115 Centre Ave
3rd Floor
Pittsburgh, PA 152321301
Telephone
412-235-1020Registry record last updated 23 Sept 2021.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Caris MPI, Inc.Program year20251 payment
- Celgene CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.7%Corticosteroid31.4%Prednisone100%Part D≥40 patientsSerotonin-3 Receptor Antagonist5.8%Ondansetron Hcl100%Part D≥14 patients+ 2 more classes in this area
Cancer & immunology
33.2%Cytochrome P450 17A1 Inhibitor13.6%Abiraterone Acetate100%Part D≥16 patientsGonadotropin Releasing Hormone Receptor Antagonist13.1%Orgovyx100%Part D≥17 patients+ 1 more class in this area
Nervous system
9.3%Gabapentinoids6%Gabapentin100%Part D<11 patientsPhenothiazine3.3%Prochlorperazine Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Extraction of Treatments and Responses From Non–Small Cell Lung Cancer Clinical Notes Using Natural Language Processing
JCO Clinical Cancer Informatics
2026 - Clinical outcomes in the real-world utilization of 177Lu-PSMA 617 in metastatic castrate-resistant prostate cancer.
Journal of Clinical Oncology
2026 - Real-world ARPI utilization patterns and outcomes in metastatic castration-sensitive prostate cancer.
Journal of Clinical Oncology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”